ID

12175

Description

A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Keywords

Versions (2)
  1. 10/6/15 10/6/15 -
  2. 10/6/15 10/6/15 - Martin Dugas
Uploaded on

October 6, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

German English

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

1 forms  
Inclusion criteria
Description

Inclusion criteria

Alias
UMLS CUI-1
C1512693
Adult Patient (>=18 years) with granulocytopenia (absolute number neutrophil: <=500 / ul) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
Description

Adult Patient (≥ 18 years) with granulocytopenia (absolute number neutrophil: ≤500 / μl) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A

Data type

boolean

Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
Description

Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A

Data type

boolean

Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
Description

Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples

Data type

boolean

For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
Description

For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation

Data type

boolean

Life expectancy ≥5 days
Description

Life expectancy ≥5 days

Data type

boolean

Treatment in one of said test centers
Description

Treatment in one of said test centers

Data type

boolean

Adequate renal and hepatic function in accordance with the following definitions
Description

Adequate renal and hepatic function in accordance with the following definitions

Data type

boolean

Bilirubin Total: ≤ 3x upper reference value
Description

Bilirubin Total: ≤ 3x upper reference value

Data type

boolean

SGOT or SGPT: ≤ 3x upper reference value
Description

SGOT or SGPT: ≤ 3x upper reference value

Data type

boolean

Alkaline phosphatase: ≤ 5x upper reference value
Description

Alkaline phosphatase: ≤ 5x upper reference value

Data type

boolean

Creatinine i. S.: ≤ 2x the upper reference value
Description

Creatinine i. S.: ≤ 2x the upper reference value

Data type

boolean

Written informed consent of the patient or the legal representative
Description

Written informed consent of the patient or the legal representative

Data type

boolean

Exclusion criteria
Description

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Participate in this study at an earlier date
Description

Participate in this study at an earlier date

Data type

boolean

Serious psychiatric pre-/concomitant disease
Description

Serious psychiatric pre-/concomitant disease

Data type

boolean

Pregnancy or lactation
Description

Pregnancy or lactation

Data type

boolean

Women of childbearing age with insufficient or unsecured contraception
Description

Women of childbearing age with insufficient or unsecured contraception

Data type

boolean

Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
Description

Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)

Data type

boolean

Patient with pathological function parameters of liver and kidney function
Description

Patient with pathological function parameters of liver and kidney function

Data type

boolean

Total bilirubin:> 3x upper reference value
Description

Total bilirubin:> 3x upper reference value

Data type

boolean

SGOT or SGPT:> 3x upper reference value
Description

SGOT or SGPT:> 3x upper reference value

Data type

boolean

Alkaline phosphatase:> 5x the upper reference value
Description

Alkaline phosphatase:> 5x the upper reference value

Data type

boolean

Creatinine i. S.:> 2x upper reference value
Description

Creatinine i. S.:> 2x upper reference value

Data type

boolean

Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
Description

Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites

Data type

boolean

Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
Description

Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days

Data type

boolean

Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
Description

Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine

Data type

boolean

Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
Description

Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B

Data type

boolean

Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
Description

Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study

Data type

boolean

Missing or incomplete consent
Description

Missing or incomplete consent

Data type

boolean

Back to the top of the page

Similar models

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Adult Patient (≥ 18 years) with granulocytopenia (absolute number neutrophil: ≤500 / μl) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
Item
Adult Patient (>=18 years) with granulocytopenia (absolute number neutrophil: <=500 / ul) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
boolean
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
Item
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
boolean
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
Item
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
boolean
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
Item
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
boolean
Life expectancy ≥5 days
Item
Life expectancy ≥5 days
boolean
Treatment in one of said test centers
Item
Treatment in one of said test centers
boolean
Adequate renal and hepatic function in accordance with the following definitions
Item
Adequate renal and hepatic function in accordance with the following definitions
boolean
Bilirubin Total: ≤ 3x upper reference value
Item
Bilirubin Total: ≤ 3x upper reference value
boolean
SGOT or SGPT: ≤ 3x upper reference value
Item
SGOT or SGPT: ≤ 3x upper reference value
boolean
Alkaline phosphatase: ≤ 5x upper reference value
Item
Alkaline phosphatase: ≤ 5x upper reference value
boolean
Creatinine i. S.: ≤ 2x the upper reference value
Item
Creatinine i. S.: ≤ 2x the upper reference value
boolean
Written informed consent of the patient or the legal representative
Item
Written informed consent of the patient or the legal representative
boolean
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Participate in this study at an earlier date
Item
Participate in this study at an earlier date
boolean
Serious psychiatric pre-/concomitant disease
Item
Serious psychiatric pre-/concomitant disease
boolean
Pregnancy or lactation
Item
Pregnancy or lactation
boolean
Women of childbearing age with insufficient or unsecured contraception
Item
Women of childbearing age with insufficient or unsecured contraception
boolean
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
Item
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
boolean
Patient with pathological function parameters of liver and kidney function
Item
Patient with pathological function parameters of liver and kidney function
boolean
Total bilirubin:> 3x upper reference value
Item
Total bilirubin:> 3x upper reference value
boolean
SGOT or SGPT:> 3x upper reference value
Item
SGOT or SGPT:> 3x upper reference value
boolean
Alkaline phosphatase:> 5x the upper reference value
Item
Alkaline phosphatase:> 5x the upper reference value
boolean
Creatinine i. S.:> 2x upper reference value
Item
Creatinine i. S.:> 2x upper reference value
boolean
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
Item
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
boolean
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
Item
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
boolean
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
Item
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
boolean
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
Item
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
boolean
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
Item
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
boolean
Missing or incomplete consent
Item
Missing or incomplete consent
boolean
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial